Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             74 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Acknowledgements
8 1S6 p.
artikel
2 Disclaimer
8 1S6 p.
artikel
3 Editorial Board
8 1S6 p.
artikel
4 KSMO Officers and Information
8 1S6 p.
artikel
5 OP01-1 A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19 -17) Kang, Eun Joo

8 1S6 p.
artikel
6 OP01-3 A phase II study on the efficacy of regorafenib in treating patients with c-KIT-mutated metastatic malignant melanoma that progressed after previous treatment (KCSG-UN-14-13) Kim, Kyoo Hyun

8 1S6 p.
artikel
7 OP01-5 Combination immunotherapy targeting XBP1, CD138 and CS1 with cancer vaccine, checkpoint inhibitors, immune modulator, and epigenetic regulator to treat patients with myeloma or solid tumours: Clinical applications Bae, Jooeun

8 1S6 p.
artikel
8 OP02-2 Luminal-to-basal subtype conversion is associated with TP53-GATA3 mutational status in patients with advanced breast cancer Ryu, Won-Ji

8 1S6 p.
artikel
9 OP02-5 Prospective trial for clinical utility of cancer whole-genome sequencing in adult solid tumors Kwon, Minsuk

8 1S6 p.
artikel
10 OP02-1 Safety and efficacy of eribulin in patients with advanced or metastatic breast cancer previously treated with anthracycline and taxane in real-world clinical practice: Data from post-marketing surveillance in Korea Chae, Yee Soo

8 1S6 p.
artikel
11 PP061 Advances in methylation analysis of liquid biopsy: Enhancing the diagnostic performance of MRE-seq for early cancer detection and cancer signal origin Kwon, Hyuk-Jung

8 1S6 p.
artikel
12 PP464 A machine learning-based prognostic model to predict survival in patients with advanced cancer admitted to an acute palliative care unit Jung, Eun Hee

8 1S6 p.
artikel
13 PP458 Analysis of dyads between oncology nurses and cancer patients on tele-consultation to develop chatbot for management of chemotherapy-induced adverse events Yoon, Junghee

8 1S6 p.
artikel
14 PP212 A phase 1B/2 study of trastuzumab, bevacizumab with paclitaxel for HER2-positive gastric cancer in a second-line therapy (TREAZURE) Koo, Dong-Hoe

8 1S6 p.
artikel
15 PP082 Assessing depression in cancer patients. Results from the 2020 Korea National Health and Nutrition Examination Survey (KNHANES) on the validity of the PHQ-9 Brzoska, Patrick

8 1S6 p.
artikel
16 PP442 Blood circulating tumor DNA-based genomic profiling in patients with advanced biliary tract cancer Jo, Hyunji

8 1S6 p.
artikel
17 PP146 Breast cancer classification: Leveraging statistical parameters from magnetic resonance imaging images with the gradient boosting algorithm Fajar, Rifaldy

8 1S6 p.
artikel
18 PP149 CD24hiCD27+Bregs within mLN orchestrate the stemness and multi-drug resistance of breast cancer cells via direct contact-interaction Ni, Chao

8 1S6 p.
artikel
19 PP153 Characterizing the relationship between DNA-methylation quantitative trait loci (mQTL), expression quantitative trait loci (eQTL), and breast cancer risk Ho, Peh Joo

8 1S6 p.
artikel
20 PP172 Comparative analysis of efficacy of first-line CDK 4/6 inhibitor plus endocrine therapy in HR-positive, Her2-negative metastatic breast cancer: Real world experience Prateepchaiboon, Tanaporn

8 1S6 p.
artikel
21 PP047 Concomitant 177Lu-DOTATATE and low dose capecitabine versus 177Lu-DOTATATE alone in patients with advanced well-differentiated gastroenteropancreatic neuroendocrine tumours – a randomized controlled trial Sood, Ashwani

8 1S6 p.
artikel
22 PP402 Correlation of plasma cytokine levels and tumor response after EGFR tyrosine kinase inhibitor treatment in advanced EGFR-mutated non-small cell lung cancer Pakvisal, Nussara

8 1S6 p.
artikel
23 PP079 Country contribution of investigators to pivotal clinical trials and their primary publications of new oncology drugs approved by the US Food and Drug Administration Choi, Yoona

8 1S6 p.
artikel
24 PP136 De-escalation of breast cancer surgery in patients with pathologic complete response (pCR) after neoadjuvant therapy confirmed by vacuum-assisted biopsy (VAB) Amirov, Nikolay

8 1S6 p.
artikel
25 PP132 Developing prompts from large language model for extracting clinical information from pathological and ultrasound findings in breast cancer Choi, Hyeon Seok

8 1S6 p.
artikel
26 PP052 Development of an anti-PDL1 scFv-kynureninase fusion protein as a probe for degrading cancer-cell secreted kynurenine Do, Hee

8 1S6 p.
artikel
27 PP054 Development of doxorubicin-loaded PLGA nanoparticles for improved cholangiocarcinoma treatment Maphanao, Pornpattra

8 1S6 p.
artikel
28 PP441 Development of novel therapeutic agents for pancreatic cancer from the perspective of precision medicine and cancer stem cell markers Matsuo, Yoichi

8 1S6 p.
artikel
29 PP008 Differential regulation of miR-3934 and its impact on metastatic potential in breast cancer cell lines Ho, Wan Yong

8 1S6 p.
artikel
30 PP317 Dissecting the mechanisms of the cross-talk between ovarian cancer cells and adipocytes: A new role for extracellular vesicles Fontana, Fabrizio

8 1S6 p.
artikel
31 PP215 Early change in circulatory PD-1+CD8+ T cells predicts durable response and survival in patients with advanced gastric cancer receiving chemotherapy Shin, Kabsoo

8 1S6 p.
artikel
32 PP248 Efficacy and safety of fruquintnib plus biweekly TAS-102 and stereotactic body radiotherapy(SBRT) for metastatic colorectal cancer: A multicenter phase II trial Wang, Yi

8 1S6 p.
artikel
33 PP399 Efficacy and safety of immunotherapy combined with chemotherapy in patients with advanced large cell neuroendocrine carcinoma of the lung (LCNEC) Li, Yintao

8 1S6 p.
artikel
34 PP074 Efficacy of breath-guided virtual reality for pain management in cancer patients undergoing percutaneous transhepatic biliary drainage: A randomized controlled study Kim, Moonho

8 1S6 p.
artikel
35 PP169 Efficacy of sacituzumab govitecan for metastatic triple-negative breast cancer: A systematic review Albert, Nikolaus

8 1S6 p.
artikel
36 PP382 EGFR and HER2 exon 20 insertion mutations in non-small cell lung cancer: Clinicogenomic characteristics, diagnosis, and treatment options Lee, So Heun

8 1S6 p.
artikel
37 PP038 Elucidating surface GFAP surface expression on extracellular vesicle as glioblastoma multiforme diagnostic biomarker Low, Johannes Jun Wei

8 1S6 p.
artikel
38 PP022 Establishment of an open standard for identification of HRD and patient susceptibility to PARPi Korsholm, Lea Milling

8 1S6 p.
artikel
39 PP028 Glutamine-dependent SLC6A14 mediates SYTL4 to induce IL-8 for glutamine production from CAFs in tumor microenvironment to support gemcitabine chemoresistance in pancreatic cancer Kang, Hyeon Woong

8 1S6 p.
artikel
40 PP031 Identification and evaluation of a serum microRNA panel for screening advanced colorectal adenomas Ng, Lui

8 1S6 p.
artikel
41 PP006 Identification of a novel, deleterious variant in CARD11 as a potential diagnostic marker in Indian multiple myeloma patients Sharma, Niyati S.

8 1S6 p.
artikel
42 PP001 Identification of IL4I1 as a cancer progression target through multi-omics analyses of early-stage lung adenocarcinoma manifesting as subsolid nodules Qiu, Mantang

8 1S6 p.
artikel
43 PP395 Identification of microbial markers associated with lung cancer based on 16s rRNA analyses Han, Wenjie

8 1S6 p.
artikel
44 PP106 Identifying apoptosis-inducing genes in human osteosarcoma cell lines and their potential use in immunotherapy Shin, Min Hwa

8 1S6 p.
artikel
45 PP398 Immune checkpoint inhibitors treatment beyond progression in advanced lung cancer: A retrospective, real-world study Chen, Chao

8 1S6 p.
artikel
46 PP144 Inhibition of iron regulatory protein 2 affects sensitivity to irradiation by regulating the DNA damage response (DDR) in breast cancer cells Jeong, Yeyeong

8 1S6 p.
artikel
47 PP065 In silico genetic polymorphisms analysis of GSTP1 and their effect on platinum compound and antituberculosis drugs co-medication in lung cancer patients with tuberculosis comorbidity Hawa, Putrya

8 1S6 p.
artikel
48 PP491 Integrating single-cell and bulk RNA-seq data to identify metastasis-related T cell marker signature using machine learning algorithms to predict the overall survival of malignant melanoma Jiang, Aimin

8 1S6 p.
artikel
49 PP147 Intraoperative radiographic evaluation of the resection margins in breast-conserving surgery with the usage of digital two-point sectorography in patients with breast cancer Bondarchuk, Yana

8 1S6 p.
artikel
50 PP156 Link of ESR1 gene polymorphisms with breast cancer risk in Bangladeshi women Islam, Mohammad Safiqul

8 1S6 p.
artikel
51 PP492 177Lu-DOTATATE peptide receptor radionuclide therapy in patients with advanced neuroendocrine tumors: Asian retrospective analysis Shin, Yeokyeong

8 1S6 p.
artikel
52 PP157 Metformin prevents tumor cell growth and invasion of human hormonal breast cancer cells via the diabetes-related gene inhibition Lee, Seungbaek

8 1S6 p.
artikel
53 PP443 Microbial dysbiosis in extrahepatic cholangiocarcinoma patients: A comparison of gut and mucosal microbiome with healthy controls Kang, Sora

8 1S6 p.
artikel
54 PP064 MicroRNA 200c-3p targeting CDH1 gene polymorphism towards risk susceptibility of prostate cancer in North Indian population Prasad, Gautam

8 1S6 p.
artikel
55 PP040 Novel biomarkers and prognostic targets for prostate cancer detection Bhummaphan, Narumol

8 1S6 p.
artikel
56 PP128 Pattern and complication of reconstructed breast cancer patients who received postmastectomy radiotherapy in the National Health Insurance Service cohort Ryu, Hyejo

8 1S6 p.
artikel
57 PP069 PMC-309, a highly selective anti-VISTA antibody reverses immunosuppressive TME to immune-supportive TME Park, Cheon Ho

8 1S6 p.
artikel
58 PP151 Preclinical evaluation of NK-1 receptor antagonist and COX-2 inhibitor against i.duc MNU-induced breast cancer in female Wistar rats Singh, Madhu Tanya

8 1S6 p.
artikel
59 PP246 Preoperative sequential short-course radiation therapy and FOLFOX chemotherapy versus long-course chemoradiotherapy for locally advanced rectal cancer: A multicenter, randomized controlled trial (SOLAR trial) Kang, Min Kyu

8 1S6 p.
artikel
60 PP049 Redistribution of 8-oxo-G/AP sites hot spots mediated transcription alteration is a novel and ubiquitous mechanism in EGFR-TKI resistance of NSCLC Jing, Xinming

8 1S6 p.
artikel
61 PP048 Replication stress contributes to activation of the DNA damage response and lapatinib resistance in HER2-amplified SK-BR-3 cells Kim, So Hyeon

8 1S6 p.
artikel
62 PP051 RNA-seq analysis of CRISPR-Cas9 targeted AGR2 of breast cancer cells reveals potential modulators of its expression and secretion Mohtar, M. Aiman

8 1S6 p.
artikel
63 PP385 Single-cell RNA sequencing in metastatic lung cancer uncovers the immune cell populations related to efficacy of PD-1/PD-L1 blockades Choi, Hwajin

8 1S6 p.
artikel
64 PP381 Sintilimab combined with anlotinib in metastatic NSCLC with uncommon EGFR mutations: A prospective, single-arm, phase II trial Chen, Kaiyan

8 1S6 p.
artikel
65 PP053 SP11, a promising coumarin-imidazothiadiazole derivative, targets HSP90 and client proteins to inhibit tumor growth MV, Shahana

8 1S6 p.
artikel
66 PP495 The alteration of iron metabolism-regulatory protein prompted melanoma cell death through the collapse of the DREAM complex Won, Soseul

8 1S6 p.
artikel
67 PP171 Therapeutic influence of simvastatin on MCF-7 and MDA-MB-231 breast cancer cells via mitochondrial depletion and improvement in chemosensitivity of cytotoxic drugs Parmar, Hamendra Singh

8 1S6 p.
artikel
68 PP213 Three-year follow-up of the ATTRACTION-4 Korean subgroup analysis: First-line (1L) nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with previously untreated, advanced, or recurrent gastric/gastro-esophageal junction (G/GEJ) cancer Ryu, Min-Hee

8 1S6 p.
artikel
69 PP063 Tobacco-derived miRNAs and their crosstalk with human transcripts towards carcinogenesis: A cross-kingdom approach Patel, Saumya

8 1S6 p.
artikel
70 PP401 Toxicity and efficiency of EGFR-TKI for poor performance status non-small cell lung cancer with EGFR driver mutation: A retrospective analysis in a single institution Akazawa, Yuki

8 1S6 p.
artikel
71 PP499 3-weekly daratumumab-based quadruplet induction regimen is highly effective in newly diagnosed multiple myeloma Tang, Hoi Ki Karen

8 1S6 p.
artikel
72 PP460 Which chemotherapy information do cancer patients and caregivers have difficulty to understand? Lee, Seyoung

8 1S6 p.
artikel
73 Table of Contents
8 1S6 p.
artikel
74 Title Page
8 1S6 p.
artikel
                             74 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland